<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">World J Surg Oncol</journal-id>
      <journal-title-group>
        <journal-title>World Journal of Surgical Oncology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25951872</article-id>
      <article-id pub-id-type="pmc">4434570</article-id>
      <article-id pub-id-type="publisher-id">589</article-id>
      <article-id pub-id-type="doi">10.1186/s12957-015-0589-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Meng</surname>
            <given-names>Tong</given-names>
          </name>
          <address>
            <email>mengtong@medmail.com.cn</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Zhou</surname>
            <given-names>Wang</given-names>
          </name>
          <address>
            <email>brilliant212@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Li</surname>
            <given-names>Bo</given-names>
          </name>
          <address>
            <email>liliunit@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yin</surname>
            <given-names>Huabin</given-names>
          </name>
          <address>
            <email>yinhuabin@aliyun.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Zhenxi</given-names>
          </name>
          <address>
            <email>zhenxili.ecnu@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Lei</given-names>
          </name>
          <address>
            <email>zl8160@qq.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kong</surname>
            <given-names>Jinhai</given-names>
          </name>
          <address>
            <email>21474392@qq.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yan</surname>
            <given-names>Wangjun</given-names>
          </name>
          <address>
            <email>oyanwangjun@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Xinghai</given-names>
          </name>
          <address>
            <email>cnspineyang@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Tielong</given-names>
          </name>
          <address>
            <email>oliutielong@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Song</surname>
            <given-names>Dianwen</given-names>
          </name>
          <address>
            <email>songdw@sh163.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Xiao</surname>
            <given-names>Jianru</given-names>
          </name>
          <address>
            <email>jianruxiao83@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department of Bone Tumor Surgery, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai, China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>13</volume>
      <elocation-id>176</elocation-id>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Meng et al.; licensee BioMed Central. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Tumor-induced osteomalacia (TIO) is a rare disorder, which is commonly found in craniofacial locations and in the extremities. To the best of our knowledge, only 16 cases have been described in the spine, and this is the first report to describe a case of patient with TIO in the thoracic spine combined with a mesenchymal hamartoma which had confused the therapeutic strategies to date.</p>
        </sec>
        <sec>
          <title>Case description</title>
          <p>We report the case of a 60-year-old patient with hypophosphatemia and presented with limb weakness. Treating with phosphate did not correct the hypophosphatemia and an <sup>111</sup>In pentetreotide scintigraphy (octreotide scan) revealed an increased uptake at the right forearm. The tumor was resected totally, and the histopathology revealed a mesenchymal hamartoma, but we noticed that hypophosphatemia was not corrected after the tumor resection. Then a whole-body magnetic resonance imaging (WB-MRI) was performed and the results revealed tumorous tissues at the right T1 vertebral pedicle. The tumor was removed with an en bloc method, and the pathology showed phosphaturic mesenchymal tumor. Follow-up at 1 year after surgery revealed no recurrence, and the serum phosphorus level of the patient was normal.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Tumor-induced osteomalacia is exceedingly rare with only 16 cases in spine published in the literature. It is difficult to find and leads to years of suffering debilitating complications. In this regard, the WB-MRI is a better method to locate the real tumor. Treating with phosphate can only relieve symptoms, and a complete surgical removal remains the gold standard treatment.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12957-015-0589-3) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Tumor-induced osteomalacia</kwd>
        <kwd>Phosphaturic mesenchymal tumor</kwd>
        <kwd>Hypophosphatemia</kwd>
        <kwd>Thoracic spine</kwd>
        <kwd>Tumor</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Tumor-induced osteomalacia (TIO), also known as oncogenic osteomalacia, is a rare paraneoplastic syndrome, which is characterized by hyperphosphaturia, hypophosphatemia, and increased levels of alkaline phosphatase [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref>]. Clinical characteristics often include bone pain, pathologic fractures, and musculoskeletal weakness [<xref ref-type="bibr" rid="CR3">3</xref>], which are related to renal phosphate wasting and resultant reduction in bone mineralization [<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref>]. TIO was first described in 1947 by McCance and colleagues [<xref ref-type="bibr" rid="CR6">6</xref>] who reported a 15-year-old girl exhibiting osteomalacia with vitamin D resistance. Unfortunately, he did not attribute her osteomalacia to femoral tumor.</p>
      <p>In this report, we illustrate the clinical presentation and therapeutic strategy of a patient with a TIO in thoracic spine. He underwent an en bloc resection to attain oncological and metabolic control. To date, about 300 cases have been described in the world&#x2019;s literature [<xref ref-type="bibr" rid="CR7">7</xref>], and only 16 cases were located in the spine [<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR8">8</xref>-<xref ref-type="bibr" rid="CR19">19</xref>]. To our best knowledge, it is the first report to describe a mesenchymal hamartoma which confused the real location of TIO. In this report, we also comprehensively reviewed those cases of TIO in spine published in the English language literature, paying particular attention to the clinical presentation and therapeutic strategy of the reported tumors.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>The patient, a 60-year-old man, first noticed pain in his right foot in 2007. In 2008, he came to the primary hospital presenting with low back pain, gait disturbance, and muscle weakness in the right lower limb. Radiological examination did not reveal any pathologic change in the lumbar vertebrae, whereas a bone scan revealed markedly increased bone uptake at the whole skeleton, and positron emission tomography/computed tomography (PET/CT) revealed mild increased uptake at multiple ribs and right femoral trochanter. No regular treatment was performed. Then the patient&#x2019;s symptoms were progressively worsened and he became disabled. In 2010, blood examination revealed hypophosphatemia (0.5 mg/dl; normal range 0.98 to 1.62 mg/dl), hypocalcemia (2.17 mmol/L; normal range 2.25 to 2.75 mmol/L), reduced 1,25-dihydroxy vitamin D (10.5 pg/ml; normal range 11.1 to 42.9 pg/ml), and elevated &#x3B2;-C-terminal telopeptide of type I collagen (CTX) (1426 pg/L; normal range 100 to 650 pg/L). Osteomalacia was initially diagnosed and treated with phosphate, calcium, vitamin D, and calcitriol. Although blood examination still revealed hypophosphatemia (0.55 mg/dl), symptoms got better progressively. In 2012, an <sup>111</sup>In pentetreotide scintigraphy (octreotide scan) was performed, and the result revealed a markedly increased uptake at the right forearm. The tumor was resected totally, and the histopathology revealed a mesenchymal hamartoma, but we noticed that hypophosphatemia wasn&#x2019;t corrected after the tumor resection. In 2013, the patient suffered paraplegia and then a PET/CT scan was performed. Unfortunately, PET/CT scan did not locate the tumor, and thus, he underwent to a whole-body magnetic resonance imaging (WB-MRI), which revealed tumorous tissues at the right T1 vertebral pedicle.</p>
      <p>The 60-year-old man was presented to our spine tumor center for consultation regarding resection of the tumor in the right T1 vertebral pedicle. On presentation to our center, the patient had signs of severe osteomalacia, and the patient&#x2019;s most outstanding complaints were diffuse bone pain throughout the whole skeleton, limb weakness, hypaesthesia, and disabled walking. Physical examination revealed that motor strength was graded as 3/5 in the upper limbs and 1/5 in the lower limbs. Sensation decreased slightly throughout, with hyporeflexia. The Hoffmann sign and the Babinski sign were negative.</p>
      <p>Blood tests revealed hypophosphatemia (0.51 mg/dl), hypocalcemia (2.15 mmol/L), elevated levels of parathyroid hormone (PTH) (72.3 pg/mL; normal range 12 to 65 pg/mL), normal serum alkaline phosphatase (ALP) levels (313 U/L; normal range 115 to 359 U/L), and normal levels of 1,25-dihydroxy vitamin D (21.01 pg/ml).</p>
      <p>Radiological exams demonstrated osteolytic changes of the T1 right vertebral pedicle and mild collapse of the T1 vertebral body. In addition, some fractures were detected in multiple ribs. MRI revealed a tumor in the T1 vertebral body and right vertebral pedicle (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). The tumor showed iso-signal intensity on a T1-weighted image (T1WI), high-signal intensity on T2WI, and was heterogeneously enhanced by gadolinium.<fig id="Fig1"><label>Figure 1</label><caption><p>Preoperative gadolinium-enhanced T1-weighted magnetic resonance image (MRI). Axial image shows osteolytic lesion with a relatively smooth margin in the T1 right vertebral pedicle and heterogeneously enhanced with gadolinium.</p></caption><graphic xlink:href="12957_2015_589_Fig1_HTML" id="MO1"/></fig></p>
      <sec id="Sec3">
        <title>Surgery</title>
        <p>Written informed consent was obtained. We decided to remove the whole metabolically active tissue via an en bloc method, and bilateral vertebral pedicles were used to accomplish spinal reconstruction. Care was taken to resect the tumor around its margins, and cuts were made in the bone outside of the tumor margin to minimize spillage of tumor. A titanium mesh cage was placed in the position of the T1 vertebral body and was packed with recombinant human BMP-2 matrix. A gross total resection was performed without intraoperative complications, and the specimen was sent for pathologic diagnosis (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Figure 2</label><caption><p>Tumor specimen.</p></caption><graphic xlink:href="12957_2015_589_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec4">
        <title>Histopathology</title>
        <p>The cells appeared spindled with normochromatic, small nuclei, and indistinct nucleoli. No significant nuclear atypia and mitoses were found. The tumor cells were focally embedded in a myxochondroid and osteoid-like matrix and contained cystic spaces of many sizes, including large dilated spaces filled with blood (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>a). The tumor was well-vascularized, and bone invasion was focally present (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>b). Immunohistochemical staining was positive for CD34 (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>c), Vimentin, and S100, with a quite low proliferation index (Ki-67 1% to 3%). Phosphaturic mesenchymal tumor (PMT) was diagnosed in the patient.<fig id="Fig3"><label>Figure 3</label><caption><p>Histopathology of the tumor. <bold>(a)</bold> The tumor mainly comprises short spindle cells with deeply stained nuclei. Few mitoses are observed (Hematoxylin and eosin [H &amp; E]); <bold>(b)</bold> Some areas of vascular proliferation show larger vessels arranged in a &#x2018;staghorn&#x2019; pericytoma pattern; <bold>(c)</bold> Immunostaining for CD34 reveals many tumor cells with positive staining in the cytoplasm.</p></caption><graphic xlink:href="12957_2015_589_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec5">
        <title>Follow-up</title>
        <p>After surgery, the patient stayed in bed for 1 month, and 1.5 &#x3BC;g/day of calcitriol was orally administered. The clumsiness and muscle weakness in both legs of the patient gradually improved, with motor strength graded as 4/5 in the lower limbs at the 6 months follow-up and the grade remained at this level thereafter (Figure&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a). When he walked, he wore a cervicothoracic brace. The patient experienced no multiple bone pain or new neurologic deficits during the 1-year follow-up period. One year after the surgery, the patient had normal neurologic function, normal triceps, biceps knee, and ankle jerks, and he returned to work. Serum phosphorus levels slightly fluctuated, but the levels remained within the normal range (Figure&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>b). Bone union without loss of cervicothoracic physiological curvature was confirmed by radiological examination at the 1-year follow-up. No evidence of recurrent tumor was detected in the MRI. The patient had no osteomalacic symptoms, and no new fractures were detected. In addition, we confirmed the accurate bony union of the fractured ribs.<fig id="Fig4"><label>Figure 4</label><caption><p>Follow-up. <bold>(a)</bold> Change of motor strength Change; <bold>(b)</bold> Change of serum phosphorus level.</p></caption><graphic xlink:href="12957_2015_589_Fig4_HTML" id="MO4"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec6" sec-type="discussion">
      <title>Discussion</title>
      <p>Osteomalacia is a metabolic bone disorder characterized by impaired mineralization of osteoid matrix in mature bone. It is most commonly caused by rare inborn disorders of metabolism, such as inherited hypophosphatemic rickets and X-linked hypophosphatemia (XLH), or may be associated with more common processes such as renal failure [<xref ref-type="bibr" rid="CR11">11</xref>]. TIO is the most unusual type of osteomalacia, which is commonly found in craniofacial locations and in the extremities [<xref ref-type="bibr" rid="CR1">1</xref>], along with long-standing hypophosphatemia [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref>]. This article presents an unusual case of phosphaturic mesenchymal tumor in the thoracic spine. To our best knowledge, including this one, only 16 TIOs have been described in the English literature in spine (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Characteristics of spinal cases of TIO</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Number</bold>
</th><th>
<bold>Authors, year</bold>
</th><th>
<bold>c</bold>
</th><th>
<bold>Age, sex</bold>
</th><th>
<bold>Period (years)</bold>
</th><th>
<bold>symptoms</bold>
</th><th>
<bold>Preoperative lab</bold>
</th><th>
<bold>Treatment</bold>
</th><th>
<bold>Histological diagnosis</bold>
</th><th>
<bold>Outcomes</bold>
</th></tr></thead><tbody><tr valign="top"><td>1</td><td>Boriani et al, 1978 [<xref ref-type="bibr" rid="CR8">8</xref>]</td><td>S1-3</td><td>18, M</td><td>DNMI</td><td>Bone pain, weakness</td><td>Hypophosphatemia, elevated ALP</td><td>Complete resection, radiotherapy</td><td>Osteosarcoma</td><td>NOLF</td></tr><tr valign="top"><td>2</td><td>Stone et al, 1992 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td>T3-4</td><td>33, F</td><td>DNMI</td><td>Bone pain, weakness, fractures</td><td>Hypophosphatemia</td><td>Complete resection, supplementation of vitamin D, phosphate, and calcium</td><td>Neuroendocrine tumor</td><td>NOLF</td></tr><tr valign="top"><td>3</td><td>Yu et al, 1995 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td>C2</td><td>58, F</td><td>DNMI</td><td>Musculoskeletal pain, weakness</td><td>Hypophosphatemia, elevated ALP and PTH</td><td>Partial resection, supplementation of vitamin D and phosphate</td><td>PMT</td><td>PSA</td></tr><tr valign="top"><td>4</td><td>Terek et al, 2001 [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td>S1-2</td><td>14, M</td><td>1+</td><td>Bone pain, skeletal abnormalities</td><td>Hypophosphatemia, hypocalcemia, low level of vitamin D<sub>3</sub>, elevated ALP</td><td>Partial resection, chemotherapy (doxorubicin)</td><td>Osteosarcoma</td><td>PSA, ALL</td></tr><tr valign="top"><td>5</td><td>Dissanayake et al, 2003 [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td>L2</td><td>58, M</td><td>3+</td><td>Musculoskeletal pains, fractures</td><td>Hypophosphatemia, low level of vit D<sub>3</sub>, elevated ALP</td><td>Complete resection</td><td>Haemangiopericytoma</td><td>NOLF</td></tr><tr valign="top"><td>6</td><td>Folpe et al, 2004 [<xref ref-type="bibr" rid="CR5">5</xref>]</td><td>C1</td><td>32, F</td><td>4</td><td>DNMI</td><td>DNMI</td><td>Partial resection, radiotherapy</td><td>Malignant PMTMCT</td><td>PSA recurrence</td></tr><tr valign="top"><td>7</td><td>Chua et al, 2008 [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td>T3</td><td>34, F</td><td>1</td><td>Musculoskeletal pain, fatigue</td><td>Hypophosphatemia, hypocalcemia, elevated ALP and PTH</td><td>Partial resection, supplementation of phosphate and calcitriol</td><td>Plasmacytoma</td><td>DNMI</td></tr><tr valign="top"><td>8</td><td>Sciubba et al, 2009 [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td>T8</td><td>56, F</td><td>5</td><td>Bone pain, weakness, fractures</td><td>Hypophosphatemia, low level of vitamin D<sub>3</sub>, elevated ALP and PTH</td><td>Complete resection</td><td>PMT</td><td>NOLF</td></tr><tr valign="top"><td>9</td><td>Pirola et al, 2009 [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td>T4</td><td>57, M</td><td>DNMI</td><td>Fractures, paresthesias</td><td>Hypophosphatemia, low level of vitamin D<sub>3</sub>, elevated ALP and PTH</td><td>Complete resection, supplementation of vitamin D and phosphate</td><td>PMT</td><td>NOLF</td></tr><tr valign="top"><td>10</td><td>Mavrogenis et al, 2010 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td>S1</td><td>42, F</td><td>2</td><td>Bone pain, paresthesias</td><td>Normal</td><td>Complete resection</td><td>PMTMCT</td><td>NOLF</td></tr><tr valign="top"><td>11</td><td>Marshall et al, 2010 [<xref ref-type="bibr" rid="CR16">16</xref>]</td><td>T12</td><td>55, F</td><td>6+</td><td>Bone pain; fractures</td><td>Hypophosphatemia</td><td>Complete resection</td><td>PMTMCT</td><td>DNMI</td></tr><tr valign="top"><td>12</td><td>Akhter et al, 2011 [<xref ref-type="bibr" rid="CR17">17</xref>]</td><td>C5</td><td>52, M</td><td>1</td><td>Fracture</td><td>Hypophosphatemia</td><td>Complete resection, supplementation of vitamin D, and phosphate</td><td>PMTMCT</td><td>NOLF</td></tr><tr valign="top"><td>13</td><td>Gandhi et al, 2012 [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td>L4</td><td>66, F</td><td>2,</td><td>Bone pain, weakness</td><td>Hypophosphatemia, hypocalcemia, low level of vit D<sub>3</sub>, elevated ALP and PTH</td><td>Complete resection</td><td>PMTMCT</td><td>NOLF</td></tr><tr valign="top"><td>14</td><td>Nakamura et al, 2014 [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td>C5</td><td>72, M</td><td>2.5</td><td>Weakness</td><td>Hypophosphatemia, elevated ALP and PTH</td><td>Complete resection, supplementation of phosphate and calcitriol.</td><td>PMTMCT</td><td>NOLF</td></tr><tr valign="top"><td>15</td><td>Puthenveetil et al [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td>T12</td><td>61, F</td><td>7</td><td>Musculoskeletal pain, weakness, fractures</td><td>Hypophosphatemia, increased ALP</td><td>Complete resection, supplementation of calcium and phosphate</td><td>PMTMCT</td><td>NOLF</td></tr><tr valign="top"><td>16</td><td>Present case</td><td>T1</td><td>60, M</td><td>6</td><td>Bone pain, weakness, paresthesia</td><td>Hypophosphatemia, hypocalcemia, elevated PTH</td><td>Complete resection, supplementation of calcitriol</td><td>PMT</td><td>NOLF</td></tr></tbody></table><table-wrap-foot><p>PMTMCT: phosphaturic mesenchymal tumor mixed connective tissue type; PMT: phosphaturic mesenchymal tumor; DNMI: Did not mention it; PSA: persistent serum abnormalities; ALP: alkaline phosphatase; NOLF: normalization of lab findings; ALL: acute lymphocytic leukemia.</p></table-wrap-foot></table-wrap></p>
      <p>TIO can lead to debilitating complications and years of suffering. The average age of 16 cases is 48.0 (range 14 to 72) years. It occurs in any age, with preponderance around the fifth decades. Characteristically, TIO affects adults without a predilection for gender, with nine female and seven male in all the spinal TIOs. Diffuse bone pain, caused by poor bone mineralization, is the most frequent symptom in these patients [<xref ref-type="bibr" rid="CR1">1</xref>]. If treated inadequately, severe osteomalacia may lead to progressive myalgias in adults and gait disturbances, growth stunting, and skeletal deformities in children [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
      <p>Notably, one of the most challenging aspects of TIO is to find the tumor. The occult nature of TIO delays its recognition, and in our case, we employed 6 years to identify the real tumor which may attribute to the mesenchymal hamartoma in the same patient complicating the final diagnosis. In a literature review of all the TIOs [<xref ref-type="bibr" rid="CR7">7</xref>], the average time from onset of symptoms to a confirmed diagnosis often exceeds 2.5 years. Definitive treatment is further delayed by an average of 5 years due to inability to find the underlying tumor due to the characteristics of being small and slow growing and being located in peculiar or atypical sites.</p>
      <p>Typical laboratory findings include hyperphosphaturia, elevated ALP, and low serum levels of vitamin D3, which account for 14/15, 10/15, and 5/15 in the literature, respectively [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR22">22</xref>]. Hypophosphatemia is secondary to inhibition of renal phosphorus reabsorption, and the vitamin D synthetic defect blocks the compensatory rise of calcitriol stimulated by the hypophosphatemia [<xref ref-type="bibr" rid="CR22">22</xref>]. Moreover, fibroblast growth factor-23 (FGF-23), associated with iron in a pathophysiological mechanism of TIO [<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref>], is highly expressed in TIO tumors compared with normal tissues [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref>].</p>
      <p>Radiographically, it presents with bone cortical thickness, osteoporosis, and fracture [<xref ref-type="bibr" rid="CR25">25</xref>]. Unfortunately, TIO tumors could not be detected by conventional imaging techniques in all 16 cases. The classic detecting method of TIO is <sup>111</sup>In pentetreotide scintigraphy (octreotide scan), a scanning technique that detects the expression of somatostatin receptors (SSTRs) [<xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref>]. However, a nonspecific uptake may cause a false-positive scan due to inflammatory tissues, fractures, or other tumor, as lymphocytes can express octreotide receptors, and moreover, a negative octreotide scan cannot exclude a diagnosis of TIO. False-positive scan emphasizes the need to further identify the tumor by PET/CT or WB-MRI exams. Successful tumor localization has also been reported in some patients with PET/CT [<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref>]. However, considering the small and occult nature of TIO, it might not be seen as increased uptake of PET/CT utilization [<xref ref-type="bibr" rid="CR30">30</xref>]. WB-MRI has been well established to have no radiological exposure and offers excellent contrast resolution of bone, soft tissue, and subcutaneous regions. Moreover, majority of TIOs which had been reported to be located in the bone, soft tissue, and subcutaneous region have a small size. Accordingly, WB-MRI is advantageous for detecting such kinds of tumor [<xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref>].</p>
      <p>The ideal treatment for TIO is complete tumor resection, and this corrects the biochemical abnormalities and remineralizes the bone substance in most cases (12/16) [<xref ref-type="bibr" rid="CR33">33</xref>]. The partial resection (4/16) might also lead to persistent serum abnormalities remained or even tumor recurrence (#6). It is worth noting that osteomalacia may reduce bone resistance and increase the risk of nonunion or lead to delayed union [<xref ref-type="bibr" rid="CR34">34</xref>]. Therefore, rigid internal fixation and effective brace should be insured [<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref>]. With regard to TIO without accurate location, the combination of vitamin D, phosphorus supplementation, and calcitriol can be used to replace progressive renal phosphorus loss, promote renal production of 1,25-dihydroxy vitamin D, and enhance renal phosphorus reabsorption. However, medical therapy cannot maintain long-term efficacy and potential complications should also be watched out, such as hyperparathyroidism, hypercalcemia, and kidney stone formation [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
    </sec>
    <sec id="Sec7" sec-type="conclusion">
      <title>Conclusion</title>
      <p>Tumor-induced osteomalacia is exceedingly rare with only 16 cases in spine published in the literature. It is difficult to find and leads to years of suffering debilitating complications. In this regard, WB-MRI is one of the important options to detect the real tumor. Treating with phosphate can only relieve symptoms, and completing surgical removal remains the modality of choice.</p>
    </sec>
    <sec id="Sec8">
      <title>Consent</title>
      <p>Written informed consent was obtained from each patient for publication of this study and the accompanying images.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>Tong Meng, Wang Zhou and Bo Li contributed equally to this work.</p>
      </fn>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>KJH, YXH, YWJ, SDW and XJR performed the surgery; YHB, LZX, ZL and LTL collected the patients&#x2019; clinical data; MT, ZW and LB analysed the data and wrote the paper. All authors read and approved the final manuscript.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; information</bold>
        </p>
        <p>Tong Meng, Wang Zhou, Bo Li can be regarded as first authors.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Dr. Chunyan Xia who prepared pathological images. We thank all patients and their families who agreed to publish the clinical data.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Beur SM</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Tumor-induced osteomalacia</article-title>
          <source>JAMA</source>
          <year>2005</year>
          <volume>294</volume>
          <fpage>1260</fpage>
          <lpage>1267</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.294.10.1260</pub-id>
          <pub-id pub-id-type="pmid">16160135</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Econs</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Drezner</surname>
              <given-names>MK</given-names>
            </name>
          </person-group>
          <article-title>Tumor-induced osteomalacia - unveiling a new hormone</article-title>
          <source>N Engl J Med</source>
          <year>1994</year>
          <volume>330</volume>
          <fpage>1679</fpage>
          <lpage>1681</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199406093302310</pub-id>
          <pub-id pub-id-type="pmid">8177274</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carpenter</surname>
              <given-names>TO</given-names>
            </name>
          </person-group>
          <article-title>Oncogenic osteomalacia - a complex dance of factors</article-title>
          <source>N Engl J Med</source>
          <year>2003</year>
          <volume>348</volume>
          <fpage>1705</fpage>
          <lpage>1708</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMe030037</pub-id>
          <pub-id pub-id-type="pmid">12711747</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weidner</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Santa Cruz</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets</article-title>
          <source>Cancer</source>
          <year>1987</year>
          <volume>59</volume>
          <fpage>1442</fpage>
          <lpage>1454</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19870415)59:8&lt;1442::AID-CNCR2820590810&gt;3.0.CO;2-Q</pub-id>
          <pub-id pub-id-type="pmid">3545439</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Folpe</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Fanburg-Smith</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Billings</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Bisceglia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bertoni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>JY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature</article-title>
          <source>Am J Surg Pathol</source>
          <year>2004</year>
          <volume>28</volume>
          <fpage>1</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200401000-00001</pub-id>
          <pub-id pub-id-type="pmid">14707860</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mc</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Osteomalacia with Looser&#x2019;s nodes (Milkman&#x2019;s syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years</article-title>
          <source>Q J Med</source>
          <year>1947</year>
          <volume>16</volume>
          <fpage>33</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="pmid">20296654</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Xing</surname>
              <given-names>XP</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature</article-title>
          <source>J Bone Miner Res</source>
          <year>2012</year>
          <volume>27</volume>
          <fpage>1967</fpage>
          <lpage>1975</lpage>
          <pub-id pub-id-type="doi">10.1002/jbmr.1642</pub-id>
          <pub-id pub-id-type="pmid">22532501</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boriani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Campanacci</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Osteoblastoma associated with osteomalacia (presentation of a case and review of the literature)</article-title>
          <source>Ital J Orthop Traumatol</source>
          <year>1978</year>
          <volume>4</volume>
          <fpage>379</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="pmid">553864</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stone</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Quincey</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hosking</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>A neuroendocrine cause of oncogenic osteomalacia</article-title>
          <source>J Pathol</source>
          <year>1992</year>
          <volume>167</volume>
          <fpage>181</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="doi">10.1002/path.1711670204</pub-id>
          <pub-id pub-id-type="pmid">1378890</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Raymond</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Gagel</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Allison</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McCutcheon</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Oncogenous osteomalacia: fine needle aspiration of a neoplasm with a unique endocrinologic presentation</article-title>
          <source>Acta Cytol</source>
          <year>1995</year>
          <volume>39</volume>
          <fpage>831</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="pmid">7631565</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terek</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Nielsen GP:Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2001. A 14-year-old with abnormal bones and a sacral mass</article-title>
          <source>N Engl J Med</source>
          <year>2001</year>
          <volume>345</volume>
          <fpage>903</fpage>
          <lpage>908</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMcpc010029</pub-id>
          <pub-id pub-id-type="pmid">11565524</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chua</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>O&#x2019;Connor</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Ganatra</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Case report: solitary plasmacytoma of bone with oncogenic osteomalacia: recurrence of tumour confirmed by PET/CT. A case report with a review of the radiological literature</article-title>
          <source>Br J Radiol</source>
          <year>2008</year>
          <volume>81</volume>
          <fpage>e110</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="doi">10.1259/bjr/58168443</pub-id>
          <pub-id pub-id-type="pmid">18344267</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sciubba</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Petteys</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Shakur</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Gokaslan</surname>
              <given-names>ZL</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>MT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>En bloc spondylectomy for treatment of tumor-induced osteomalacia</article-title>
          <source>J Neurosurg Spine</source>
          <year>2009</year>
          <volume>11</volume>
          <fpage>600</fpage>
          <lpage>604</lpage>
          <pub-id pub-id-type="doi">10.3171/2009.6.SPINE08120</pub-id>
          <pub-id pub-id-type="pmid">19929364</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pirola</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vergani</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Casiraghi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Leone</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Guerra</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sganzerla</surname>
              <given-names>EP</given-names>
            </name>
          </person-group>
          <article-title>Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine</article-title>
          <source>J Neurosurg Spine</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>329</fpage>
          <lpage>333</lpage>
          <pub-id pub-id-type="doi">10.3171/2009.1.SPINE08351</pub-id>
          <pub-id pub-id-type="pmid">19441990</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mavrogenis</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Sakellariou</surname>
              <given-names>VI</given-names>
            </name>
            <name>
              <surname>Soultanis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mahera</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Korres</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Papagelopoulos</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>A nonphosphaturic mesenchymal tumor mixed connective tissue variant of the sacrum</article-title>
          <source>Orthopedics</source>
          <year>2010</year>
          <volume>33</volume>
          <fpage>851</fpage>
          <pub-id pub-id-type="pmid">21053876</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Agaram</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Douglas-Akinwande</surname>
              <given-names>AC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A 61-year-old woman with osteomalacia and a thoracic spine lesion</article-title>
          <source>Brain Pathol</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>499</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1750-3639.2009.00360.x</pub-id>
          <pub-id pub-id-type="pmid">20438469</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akhter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sugrue</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Bains</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Khavkin</surname>
              <given-names>YA</given-names>
            </name>
          </person-group>
          <article-title>Oncogenic osteomalacia of the cervical spine: a rare case of curative resection and reconstruction</article-title>
          <source>J Neurosurg Spine</source>
          <year>2011</year>
          <volume>14</volume>
          <fpage>453</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="doi">10.3171/2010.11.SPINE09750</pub-id>
          <pub-id pub-id-type="pmid">21275557</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gandhi</surname>
              <given-names>GY</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Shoraka</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report</article-title>
          <source>Case Rep Endocrinol</source>
          <year>2012</year>
          <volume>2012</volume>
          <fpage>185454</fpage>
          <pub-id pub-id-type="pmid">23346426</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="other">Nakamura T, Aizawa T, Hoshikawa T, Ozawa H, Ito N, Fukumoto S, et al: Tumor-induced osteomalacia caused by phosphaturic mesenchymal tumor of the cervical spine. J Orthop Sci 2014 DOI:&#x2009;10.1007/s00776-014-0540-4</mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodgers</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Perrier</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <article-title>Parathyroid carcinoma</article-title>
          <source>Curr Opin Oncol</source>
          <year>2006</year>
          <volume>18</volume>
          <fpage>16</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1097/01.cco.0000198019.53606.2b</pub-id>
          <pub-id pub-id-type="pmid">16357559</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vollbrecht</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Images in clinical medicine</article-title>
          <source>Tumor-induced osteomalacia. N Engl J Med</source>
          <year>2008</year>
          <volume>358</volume>
          <fpage>1282</fpage>
          <pub-id pub-id-type="doi">10.1056/NEJMicm066066</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khosravi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cutler</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Royal</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Sherry</surname>
              <given-names>RM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Determination of the elimination half-life of fibroblast growth factor-23</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2007</year>
          <volume>92</volume>
          <fpage>2374</fpage>
          <lpage>2377</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2006-2865</pub-id>
          <pub-id pub-id-type="pmid">17374707</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimizu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamauchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia</article-title>
          <source>Bone</source>
          <year>2009</year>
          <volume>45</volume>
          <fpage>814</fpage>
          <lpage>816</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bone.2009.06.017</pub-id>
          <pub-id pub-id-type="pmid">19555782</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schouten</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Livesey</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Frampton</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Soule</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2009</year>
          <volume>94</volume>
          <fpage>2332</fpage>
          <lpage>2337</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2008-2396</pub-id>
          <pub-id pub-id-type="pmid">19366850</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cukierman</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gatt</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Hiller</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Chajek-Shaul</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Clinical problem-solving. A fractured diagnosis</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>353</volume>
          <fpage>509</fpage>
          <lpage>514</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMcps040047</pub-id>
          <pub-id pub-id-type="pmid">16079375</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palot Manzil</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Bhambhvani</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>O&#x2019;Malley</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of tumor-induced osteomalacia with 111In-pentetreotide scintigraphy</article-title>
          <source>J Nucl Med Technol</source>
          <year>2013</year>
          <volume>41</volume>
          <fpage>299</fpage>
          <lpage>301</lpage>
          <pub-id pub-id-type="doi">10.2967/jnmt.113.126763</pub-id>
          <pub-id pub-id-type="pmid">24159011</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nguyen</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia</article-title>
          <source>Clin Nucl Med</source>
          <year>1999</year>
          <volume>24</volume>
          <fpage>130</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="doi">10.1097/00003072-199902000-00016</pub-id>
          <pub-id pub-id-type="pmid">9988077</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hesse</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Moessinger</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rosenthal</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Laenger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Brabant</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Petrich</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography</article-title>
          <source>J Bone Miner Res</source>
          <year>2007</year>
          <volume>22</volume>
          <fpage>158</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="doi">10.1359/jbmr.060909</pub-id>
          <pub-id pub-id-type="pmid">17014386</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roarke</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <article-title>PET/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia</article-title>
          <source>Clin Nucl Med</source>
          <year>2007</year>
          <volume>32</volume>
          <fpage>300</fpage>
          <lpage>301</lpage>
          <pub-id pub-id-type="doi">10.1097/01.rlu.0000257180.03964.51</pub-id>
          <pub-id pub-id-type="pmid">17413579</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakanishi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tsuboi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Whole-body MR imaging in detecting phosphaturic mesenchymal tumor (PMT) in tumor-induced hypophosphatemic osteomalacia</article-title>
          <source>Magn Reson Med Sci</source>
          <year>2013</year>
          <volume>12</volume>
          <fpage>47</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.2463/mrms.2011-0006</pub-id>
          <pub-id pub-id-type="pmid">23474956</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fukumoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nagano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia</article-title>
          <source>Bone</source>
          <year>1999</year>
          <volume>25</volume>
          <fpage>375</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="doi">10.1016/S8756-3282(99)00170-2</pub-id>
          <pub-id pub-id-type="pmid">10495143</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Hogan</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Ahlstrom</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnosis of a patient with oncogenic osteomalacia using a phosphate uptake bioassay of serum and magnetic resonance imaging</article-title>
          <source>Eur J Endocrinol</source>
          <year>2001</year>
          <volume>145</volume>
          <fpage>469</fpage>
          <lpage>476</lpage>
          <pub-id pub-id-type="doi">10.1530/eje.0.1450469</pub-id>
          <pub-id pub-id-type="pmid">11581007</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shane</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Parisien</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Dempster</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tumor-induced osteomalacia: clinical and basic studies</article-title>
          <source>J Bone Miner Res</source>
          <year>1997</year>
          <volume>12</volume>
          <fpage>1502</fpage>
          <lpage>1511</lpage>
          <pub-id pub-id-type="doi">10.1359/jbmr.1997.12.9.1502</pub-id>
          <pub-id pub-id-type="pmid">9286768</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mankin</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Rickets, osteomalacia, and renal osteodystrophy</article-title>
          <source>Part II. J Bone Joint Surg Am</source>
          <year>1974</year>
          <volume>56</volume>
          <fpage>352</fpage>
          <lpage>386</lpage>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meng</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Therapeutic strategy and outcome of spine tumors in pregnancy: a report of 21 cases and literature review</article-title>
          <source>Spine (Phila Pa 1976)</source>
          <year>2015</year>
          <volume>40</volume>
          <fpage>E146</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="doi">10.1097/BRS.0000000000000719</pub-id>
          <pub-id pub-id-type="pmid">25423305</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meng</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center</article-title>
          <source>Neuro Oncol</source>
          <year>2015</year>
          <volume>17</volume>
          <fpage>725</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="doi">10.1093/neuonc/nou331</pub-id>
          <pub-id pub-id-type="pmid">25488908</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dissanayake</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Holdaway</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Reid</surname>
              <given-names>IR</given-names>
            </name>
          </person-group>
          <article-title>Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging</article-title>
          <source>Intern Med J</source>
          <year>2003</year>
          <volume>33</volume>
          <fpage>615</fpage>
          <lpage>616</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1445-5994.2003.00488.x</pub-id>
          <pub-id pub-id-type="pmid">14656239</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puthenveetil</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Hattab</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Peacock</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia</article-title>
          <source>J Clin Neurosci</source>
          <year>2013</year>
          <volume>20</volume>
          <fpage>1057</fpage>
          <lpage>1061</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jocn.2012.09.035</pub-id>
          <pub-id pub-id-type="pmid">23618679</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
